Top Industry News
- Health Canada-Cancellation of a Drug Identification Number (DIN) and notification of the discontinuation of sales
- Swissmedic agrees closer collaboration in therapeutic products field with Austrian partner authority
- EMA post - authorisation procedural advice for users of the centralised procedure
- MHLW - Pharmaceuticals and Medical Devices Safety Information
- MHRA-Annual review of good clinical practice referrals: 2011 to 2015
- Multiple Endpoints in Clinical Trials: Biopharma companies seek more from FDA Draft Guidance
- UK on Brexit Implications: ‘Significant Benefits’ to Remain Part of EMA